Notice of Registration - 2012
[Federal Register Volume 77, Number 24 (Monday, February 6, 2012)]
[Notices]
[Page 5849]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-2568]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 23, 2011, and published in the Federal
Register on July 5, 2011, 76 FR 39127, Johnson Matthey Pharmaceutical
Materials, Inc., Pharmaceuticals Service, 25 Patton Road, Devens,
Massachusetts 01434, made application by letter to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of
Remifentanil (9739), the basic class of controlled substance in
schedule II.
The company plans to utilize this facility to manufacture small
quantities of the listed controlled substance in bulk and to conduct
analytical testing in support of the company's primary manufacturing
facility in West Deptford, New Jersey. The controlled substances
manufactured in bulk at this facility will be distributed to the
company's customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Johnson Matthey Pharmaceutical Materials, Inc. to manufacture the
listed basic class of controlled substance is consistent with the
public interest at this time. DEA has investigated Johnson Matthey
Pharmaceutical Materials, Inc. to ensure that the company's
registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security
systems, verification of the company's compliance with state and local
laws, and a review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33,
the above named company is granted registration as a bulk manufacturer
of the basic class of controlled substance listed.
Dated: January 27, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-2568 Filed 2-3-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
